Mice that overexpress a mutated ornithine decarboxylase (ODe) transgene in outer root sheath keratinocytes of the hair follicle were used to study the role of this enzyme ill regulating hair follicle structure and function. These transgenic mice have a nornlal first hair cycle, but lose their hair completely beginning 2-3 wk after birth. Transgene overexpression in follicular keratinocytes is first detected at day 12 after birth, coincident with the development of follicular cysts in the upper portion of the dermis. The onset of keratin 6 expression also begins around day 12; because the promoter/regulatory region of the bovine keratin 6 gene was used to target ODe transgene H air growth in mi ce and other mamm~ls. including humans, I S chara cten zed by a cycli c process of fo lJjcle rege neration/hair growth (anagen), fo Uicl e involution/hair growth cessation (catagen), and a follicle re sting stage (telogen). The factors that regulate the m ammalian hair cycl e are largely unknown . although som e promising ca ndidates have e merged fi'om studies on transgenic mice: fibrobla st g rowth factor 5 (Hebert et ai, 1994) and the tra nsforming growth factor-{3 superfamily members BMP-2 and BMP-4 (Bl essing et ai, 1993). Wh ereas these growth facto rs and signaling molecules may be important humoral mediators of follicl e growth and regression, what is compl etely lacking are clues to illiface/I,dn,. reg ulators of hair follicl e activity. In an immunocytoch emi cal analysis of ornithine deca rboxyla se (ODe) expression in murine e pidermis IIerSIIS epid ermal tumors, Sund berg el al (1.994) observed hair cycl e-dependent ODe expression in follic les. In telogen follicles, ODe expression was upregulated in a small cluster of outer root sheath cell s near the so-call ed "bulge" region , whereas in anagen fo Wcles, expression was seen along most of the length of the fo Uicl e. In normal in terfollicular epidermis, elevated levels of ODe are never observed unless th e skin is treated with inducing stimuli such as phorbol es ters (O'Brien el nl, 1.975a; Weeks el nl, 19 82).
expression to hair follicle keratinocytes, these data demonstrate the faithful temporal and cell typespecific expression of the K6-driven transgene. The ODe inhibitor 2-difluoromethylornithine could prevent hair loss and partially normalize skin histology if adlninistered before the onset of ODe overexpression. 2-Difluoromethylornithine could also reactivate hair growth in animals with complete hair loss. Our results suggest that ODe is an important regulatory gene for the mouse hair follicle. Key lVords: poi)lamill es/2-dijiIlOJ'Ollletil),iol'llitllille. ] Invest Derlllatoi 106:1108-1113, 1996 of ODe might enhance susceptibili ty of epidermal keratinocytes to n eoplastic transformation. We therefore decid ed to construct transgenic mice that constitutively overexpress ODe in haiJ" foHicle keratinocytes. The resulting transgenic mice, whi ch overexl'ress ODe in outer root sh eath keratinocy te s, indeed exhibit a high freq u en cy of spontaneolls skin tumors, including keratoacanthomas, which are knowlI to develop fi'om hair follicles (Megosh et nf, 1995) . One of the other interes ting phenotyp es of these transgenic mice was hair loss beginning at 2-3 wk of age, when the second cycle of hair growth would b e expected to begin. Histologic ana lysis of the skin of adult transgen ic mi ce with complete hair loss revealed foll icular cysts in the dermis that progressively increased in size as the anima ls aged (Megosh el nl, 1995) . Because ODe is an en zyme for which potent inhibitors are availab le, we decided to ask whether modulation of ODe transgene activity co ul.d iJlftu ence hair fo llicl e function in these mi ce. If so, these transgenic mice could be a usefu l experimental model to ana lyze intrinsic and extrinsic f.~ctors that regulate the mammalian hair follide.
MATERIALS AND METHODS
Transgenic Mice The pro du ctio n of transgeni c Inice that ovcrcxprcss a mutated ODC specifi ca lly in skin has becn described in detail e1sewhcre (Mcgosh e/ "I, 1995) . For the cxperimcnts described herein, transgenic progeny from the founder lin e designated KG-55 were used. The OD C transgcll c is rnaintail1cd in the he mizygo us state by lIlatin gs of transgenic with B6C3Fl mice. Typic:dly, male hc,nizygo us transgen ic mice arc mated with normal J36 C3F l female ll1i ce to generate approximately cq llaluumbers of transgeni c pups and Ilolltrallsgcni c li ttcfmates. W hen necessary, polym era se eha_ in reaction ana lysis of tni l DNA was used to identify transgenic (nice, as described prcvio usl y (Megosh C!I nl. 1995) . W hen 2-diAuoroll1ethyl-ornithin e (.DFMO) was <ldnlil1_ istc red. it was dissolved ill drinking water at a con centration of 1 (Yr. (w / v).
I'l1munocytochclnistry Skin for both routine histology a n d ilTlIl1UUO-cytochCllli stry was fixed overnight in Fekete's solu tioll (o l lXl etha1lol , 3._% formalde hyde, 0.75 N acetic acid) and embedded in paraffin . hnrnunoc),- antiserum at '1 :3, 000 and a rabbit anti-moll se ){ (, antiserum at I :8,000. with an avidin-biotin detection system (Vecto r Laboratori es . Burlinga me. CAl.
ODC and Polyaminc An alyses Skin specim ens were separated in to epidermal and derl11 al Ii'actions by bri ef heat treatm ent (55°C, 20 s) , followed by scrapin g with a razor blade. T issues we re homogenized in buffer (25 111M Tris-HCI, pH 7.5, co ntainin g 1 mM dithi othrcitol and 0. ' 1 mM ethylenedi amin e tetraacetic acid) or 0. _ N pcrchl ori c aci d fo r O DC and poiyanlin e analyses, respecti vel y. Ass ays were co ndu cted ex ac tl y as described previously (Koza c( nl , 199 1) . For ODC activity , 1 uni t = I nnlOl CO 2 liberated/ h at 37°C.
R ES ULTS
Transgenic Mice That Ove rexpress ODC Have Multiple A bnornlalities Excep t fo r smali e r size, tra nsge ni c mi ce of bo th sexes appeared pheno typi call y Jl o rmal fo r app roxima te ly 2 w k afte r birth. They th en exhibited progress iv e hair loss, including vibrissae, whic h w as complete by 6 wk o f age. Unl ess specifica lly treat.ed (see below), al o pecia was irreversibl e. N ail growth was al so acce lerated, and as the ani mals aged , the skin becam e in crea sin g ly w rinkl ed and folde d becau se of th e increase in size and numbe r o f derm al fo lli c ul ar cys ts. Earl y in life, transge ni c mi ce w e re small er than OR.N IT HI NE DECAR.I30XYLASE AND H AIR. FOLLI CLES 11 09 norm al littermates, but w ith age, transgenic anima ls ~I c hieved similar weights as n OlTIlall11i ce. T h e weight distribution , however, was o bvio usly very different; am o ng mi ce o f similar we igh t, th e skin o f norm al mi ce represented 2 5% of total carcass weigh t, w h ereas in older transgeni c mice, skin weigh t w as 55°!., of total ca rcass weight b eca use of th e grea ter area and thickn ess of th e skin (A . Peralta So ler and T. G. O 'Brien , unp ubli sh ed data). A tran sge ni c m o use and a n o rmal age-match ed li tte rm ate are sh own in Fig  1. T h e phen otype of th ese mice resembles in so m e respects th at of rhin o mi ce, an alle li c va ri an t o f the h airl ess (lt r/"r) m o use (M ann, 1971) . Althou gh th e integration site o f th e O D e transgen e h as n ot yet bee n m appe d , it is very unlikely tb at it is at th e Itr locus on chro m oso m e 14; offspl·in g fro m six differen t fo und ers all d ispl ayed the same phen otypi c m ani fes tatio n s. M o reover, th e ODe transgcn e acts in a do min ant m ann er, w he reas th e It,. mu tatio n is recessive.
Morphologic Changes a nd Transgene Expression First Appear at About D ay 12 Afte r Birth In tran sgenic m ice th at overexpress O D C, th e first h air g ro wth phase was n orm al bu t sub sequ ent cycles did n ot occur. To d ete rmin e th e ti min g of th e o n se t of transgene express io n rela tive to m orph o logic ch an ges, we e uthani zed n on transgeni c and transgeni c p ups at 2-to 3-d in te rva ls from 2 t o 23 d after birth and prepared skin sections for histology and iml'l1un ocytoche mist.y . T h ere w as n o o b vio us di ffe ren ce in skin hi stology between n on tran sgeni c an d tran sgeni c li tte rmates un ti l da y 12 postnatall y, w hen sm all fo lli cul ar cysts and m ode rate se baceous cell h yperplasia were o bserved in transgeni c skin ( Fig  211) . By day 23, th e folli cle-de riv ed cysts were large r and m o re num ero us, and n o rm al fo llicl es we re ab sen t (Fig 2d) . In terms of O D e ex press io n , up to 10 d afte r birth the re were no apparen t difte ren ces in th e patte rn of ODC express io n in transgeni c ("TSI/S n o ntransgeni c ski n as dete rmin ed immun ocytoc hem ica ll y (data n o t sh own). At 12 d, h owever, th ere was elevate d ODe ex pression in so m e d evel o pin g cysts an d fo lli c ul ar areas of th e tr ansge ni c sk in (Fig 2/1 ) co mp ared w ith co n tro ls (F ig 2a) . By 23 d, ODe ove rexp ressio n in tran sgeni c skin w as cl earl y associated w ith developing pil ar and follicul ar cys ts (Fig 2d) , w ith weake r exp ressio n in fo lli cles of n ormal skin (Fig 2c) .
T he res ul ts of irnmunocytoche m ica l an alysis of ODe ex pression in n ew bo rn mi ce of di ffe re n t ages su ggested that the fi rst. sig ns of fo lli cul ar abno rm ali ties we re o b served in th e uppe r portion of th e fo llicl e (i. e., th e in fundibulum). As sh own in Fig Pups [ro ln a fiGC3F1 s tra n sgenic crOSS were e u th:1Il izcd at vario lls da ys after b irth. skin sa mples V lcrc ta k e n fo r histologic an d inll11un ocytochcnti ca l anal ys is. an d li ver tiss ue was removed fo r p O l r nl c r~l sc ch ai n reactio n determination oftra nsgc nc starus . n,", Secti ons From nontr;lIlsgc nic pups at 12 and 23 d aftc r birth, respective ly; !>,ri, transgeni c pups at the same ages.
Scale bar, 100 J.un. reveal any obvious abnormalities of the lower fo llicle (including the h air bulb) in transgenic mi ce.
If, as is likely, th e more inten se staining of ODe in transgenic skin at day 12 and therea fter is du e to activation of tra nsgen c expression (as opposed to expression of the end ogeno us ODe gen e), then th ere may b e a temporal association between the o nse t of keratin 6 promoter-driven ODe ex pressio n and keratin 6 expressio n itself. T his question was addressed usi ng th e same series of skin sections analyzed for ODe expressio n , except th at a pol yclonal anti-K6 antise rum was used ins tead. As sh own in Fig  4a,b , there was no evidence of K6 ex press io n in eithe r n o rmal or transgenic skin at 4 d postna tall y. T h ere was also n o hi stologic diJfe rence observed at this tim e. T he first evidence ofK6 e xpression was seen at da y 12 in n o n tran sgenic mice. Ex pression was restricted to the o uter root sh eath of anagen hair fo llicles in th e mid-dermis (Fig 4c) ; thi s is the predicted ex pressio n p attern base d on th e resu lts of others (Heid el ai , 1986; R ami rez el ai, 1995) . Inte restin gly, K6 stainin g of transgeni c skin rev ea le d a different expression pattern: Follicles on the mid-d ermis were n ega tive, bu t weak stain in g was detected in fo llicles of the upp er dermi s, some of w hich appeared to be incipient pilar cysts (Fig 4d) . This is ve ry similar to th e express ion pattern for ODe at day 12 in transgenic mice (Fig 2d) . By d ay 23, virtu ally all hai r fo llicles in non transgenic mice w ere positive (Fig 4e) , whe rea s K6 expression in transgenic mi ce was gen erall y restricted to fo ll icu lar cysts (Fig 4j) . DFMO Prevents Hair Loss To dete rmin e wh e th er ele vated tra nsgen e ex pression was directly responsibl e for the h air-loss ph enotype, we u sed DFMO, the irreversible inhibi tor of ODe. T hi s co mpound has been used in mice previo usly and is both effectiv e at inhibiting ODe and well tolerated at doses of up to 2% in the drinking water (Weeks ct ai, 1982; Takigawa el ai, 1982; Kingsnorth el ai, 1983) . Newbom pups, both transgenic and nontransgenic, were administered DFMO at 1% (w /v) in their dam 's drinkin g water. At weaning, transgenic mice (identified by polym erase chain reaction anal ysis of tai l DNA) were divid ed into two gro up s: O ne grou p was switche d to regular drinking water, and one group co ntinu ed to receive dri nkin g water containing 1% DFMO . Typically, weanling tran sgeni c mi ce h ad lost most Of all of th eir hair, but mi ce ad ministered D F MO were indistingui shable from normal B6e3F2 mi ce. All tran sge nic mi ce (n = 4) administe red DFMO fi'om birth con tinued to maintain n Ofmal-appearing ha ir coats, w h ereas those mi ce switc hed to regular drinkin g water at week 3 gra duall y lost h air and develo ped the thickened , wrinkled skin rypical of transgenic mice n ever exposed to DFMO (Fig Sa) . Histologically, skin fro m a tran sgeni c mouse maintained continuo usly on DFMO h ad no rmal, haiT-contain.in g fo lli cles (Fig 51/) , w hereas ski n from a m o use returned to regul ar drinkin g water had typi cal follicl e-derived cysts (Fig Sc) . Follicle den siry in transgenic mi ce maintained co ntinuously o n DFMO was, however, less than th at in Ilontransgeni c skin of th e sam e age.
Previo us results had indicated that ODe transgene overexpressio n in skin occ urs predomin antl y in th e dermi s, where folli cular cysts are locali zed (M egosh cl ai, 1995) . DFMO treatment wa cl ea rly effective in inhibiting ODe activity in transgeni c dermis (Table I) . Withd raw al of DFMO led to '1 recovery o f transgene exp ression, but not to levels typicall y obse rved in untreated transgen ic d ermi s (Megosb el ai, 1995; T.G . O'Brien , unpublished results). Putrescin e I.evels reflected the re lative ODe activities in tran sge ni c ski n (continuous DFMO and DFMO-withdrawn) and nontransgenic skill , whereas, curiou sly, spe rmidin e and spermine levels did not; both were e leva ted in each of th e transgenic treatm ent gro up s IICI"S IIS no rmal dermal leve ls of these polyam.ines (M egos h cl ai, 1995). T h e explanation for the eleva tio ns in spe rmidin e and spermine . l evels in m ice con tinuously adm inistered a co ncentration ofDFMO that co mpletely inhibits ODe expression is not known. T hus, it appears th at putrescine levels, and n or spermidine or spermine, in the d ermis correlate best with hair growth statu s: N o rmal (low) leve ls of p utrescin e are permissive for no rm al hair fo lli cle activity, wh ereas hi gh levels disrupt the hair cycle.
DFMO Reactivates Hair Growth To addre ss th e question of w hether transgen e inhibi tion in o lder anima ls with compl ete hair loss co uld reactivate ha ir grow th , we administere d DFMO (at 1%) in the drinkin g water to 6.5-wk-o ld transgen ic mi ce with no norm al hair fo llicles in the skin. After 2 wk of DFMO administration, hai r grow th in all treated mi ce (n = 3) had begnn (compare Fig 6a vcrs lI.\" 6b) , and b y 9 wk of drug trea tm en t, sub stantial hair growth had occurred (co mpa re F ig 6c vef S II .\" 6d) . Compared witb con trol tra n sgeni c skin (Fig 6e) , DFMO-treated skin contained n ormal hair follicl es, w ith fe wer and smaller follicular cysts (Fig 6j) . As expected , ODe and po lya min e levels were al so norm alized in DFMO-treated skin (Table II) . T hese results indicate th at trallSgene expression sufti cient to ca use co mplete hair loss does not irreversibly impair th e abiliry of fo lli cle stem cell s to gen erate norm al h air fo lli cl es .
D ISCUSSION
The transge ni c m o u se mod el we h ave described h ere and elsewhere (M egos h eI ai , 1995) implicates ODe as a ge ne that, when overexp ressed, ca n disrupt hair fo llicl e stru cture and fun ction. W e pres um e that th e effects of ODe overexp ression are medi ated by the sub sta ntial elevation s ill putrescin e, and to a lesser extent, spermidine, tbat are o bserved in the dermis of transgenic mice, beca use n o functions o the r than its en zym atic activity have b ee n rigoro usly ascri bed to ODC. ODC is almost always a very low abundance protein in norm al adult m am malian tiss ues, but Sundberg et al (1994) h ave repo rted high levels of ODC expression in anageD h air follicles, co mpared with m o re restricted expression in tel ogen follicles of adult CD-l mice. This follicular stage-specific expression of ODC in a no rm al o utb red mouse and o ur results in transgenic mice overexpressin g ODC are consistent w ith the fo llowing h ypothetical ro le for ODC (and polyamines) ill fo llicle behavior. Loca l m edi ators (fibroblast growth factors, EMPs?) induce ODC in a tran sitory fashion to trigger the anage n phase of folljcle g rowth . En zym e activity (and follicle growth) is m aintain ed by the con tinuo us presence of mediator substances. Wh en the local concentration of exogen o us r.,ctor(s) declines, ODC is de-induced , and follicles enter the cata gen phase. If ODC activ ity is con stitutively expressed at a very h igh level (as in transgenic mi ce). the resultin g higb levels of intrace llular polyamines suppress n o rm al fo lli cular beha vior and instead favor continuous proliferatio n of o uter root sheath keratinocytes to form fo llj cul ar cySts . . At least som e cell s iu th ese cysts, h owever, reta in stem cell capability on ce ODC and polyamine levels are redu ced to norm al val ues (e.g. , via DFMO admilustration) .
T he bovine K6 promoter used to driv e ODC tran sgene expressio n in this m o u se m odel appears to direct ODC expression to th e "correct" cell type in skin (outer root sheath keratinocytes), based on what is known abo u t mouse keratin 6 expressio n (Heid el nl,  198G) . In o ur comparative analysis of ke ratin G expression in normal mi ce /lers" s K6-d riven ODC expression in transgenic mi ce, we also o bserved th at expressio n of both gen es begins at th e sa m e ti m e afte r birth (ap proximately 12 d) . Our time course an alysis (every 2 d after birth) of both skin histology an d exp ression of KG and ODC in this tran sgenic m odel indicated tllat th e first evidence offollj cul a.r cys t development w as observed at 12 dafter birtll , coi ncident with the onset of both endogen o u s KG expression and ODC overexpression . . C learl y, ODC ovcrexprcssion due to activatio n of the KG-driven transgen e drives th e developm ent of abnormal ski n lustology and hair follicl e dysfun ction in thi s mode l.
Important tests of the idea tllat ODC ac ti vity is a regulator of h air follicl c function involved th e use of a highly specifi c inhibito r, DFMO, either to pre ven t the onset of ODC overexp ression or to rcdu ce es tablish ed overexpressio n to m ore n o rmal lcvels. Adm inistratio n of this drug immediately after birth , before tl'a nsgene expression was turn ed o n , was very effective in preventing higb levels of ODC expressio n and h air loss . . Somewhat surp,-isingl y, administration of the drug after high levels of ODC transgene express io n had been established (and hair loss was comple te) res ulted in reactivation of h air growth, alth ough a comple tely normal h a.ir coat was not achieved . R eapp earan ce of normal follicles was acco mpani ed by sh rinka ge and actu al di sappearan ce of som e of the follicular cysts characteristic of adult t.ran sgenic mi cc. T his result suggests that at least som c cell s in the cysts retain stem cell potential. We concludc from both sets ofDFMO cxpe riments th at intracellular polyamine levels (especiall y putrescine) act as a mol ec ular switch regUl ating the behavior of outer root sh ea th keratinocytes of th e h air follicl e: H igh levels suppo rt proli fe ration and suppress difFe rentiatio n, w h ereas low levels are permiss ive fo r differentiation bu t not permissive for prolifen'tio n. In n ormal mi ce, polyamine levels wou ld flu ctuate in response to transient elev<Itions of ODC ca used b y extracellular factors produced either locall y or syste micall y, w hereas the con stitutive overexp ress ion of ODC in tra.nsgen ic mice wou ld eliminate fl u ctuations ill pol ya min e levels and abrogate exogen o us con tro l of fo llicular keratinocyte growth and differentiation . .
A lth o ugh there are numerous mutations tha c cau se hai.r loss in mice, th e iden tity of the genes involved is n ot known in most cases (Sundberg, 1994) . Interestin g ly, mutations in another gen e invo lved in ornitlunc m eta bo li sm , orn ithin e transcarbamylase , are responsible for the "sparse fur" phen otype (Doolittle et nl , 1974; D eMars eI nl, 1976) . In transgeni c mi ce, overexpression of a sheep woo l keratin gene caused cyclic hair loss an d regrowth (Powell and Roge rs, '1990) . . In addition. transgeni c mi ce ovc rexpressin g the Table J. tran sforming growth fa ctor-related polypeptide BMP-4 driven by a K6 promoter exhibit a partial hai.r-Ioss phenotype (Blessing ct nl, 1993) . The enz ymatic activity ofODC in transgenic dennis can be effectively inhibited b y a nontoxic (J %) concentration of DFMO in rhe drinking water. Other approa ches such as an inducible transgenj c expression systel11 (Furth ct nl, 1994) co uld also be used to regul a te ODC expression levels. Using such mode ls, it should be possible to study the mechanisms involved in the loss ofnorl11al hair follicles and the morphogenesis of new follicl es, as well as the extrin sic fa ctors that regulate these events . Finaliy, does ODC regulate the hair follicle structure and function in other mammals, including humans? Because DFMO is being acti v ely evaluated as a cancer chemopre ventive agent, there have been several long-te rm chronic toxic ity studies of DFMO in both animals and humans. Takigawa et nl (1983) re ported that the only side e ffect of J % DFMO ill th e drinking water in mice undergoin g long-te rm anti-carcinogenesis expe riments was "severe re tardation of hair growth ." A l-year study of daily oral administration of DFMO to dogs and rats reported moderate to severe dermatologic reactions , including alopecia, dermatitis, and conjunctivitis (Crowell et aI, 1994) . In humans, th e dose-limiti.t1g toxi c e ffect of this compound is ototoxicity (Love el nl, 1993) , which is usually caused by chemically induced damage to the outer hair cells of the inner ear (Harrison , 1988) . The fiuding that hair folljcl es and inner-ear hair cells are among the most sensitive cell types to ODe-targeted drug tre atment suggests that pol yamin es are criti call y important mole cules in reg ul ating the growth and fun ctioning of these specia lized tissues. D efects in polyamine m etabolism. therefore, may underlie some abnormalities of skin and hair growth in humans . If so, polyamine-based therapies may hav e potential for the treatment of such diseases.
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